Literature DB >> 7875583

Detection of a functional promoter/enhancer in an intron-less human gene encoding a glutamine synthetase-like enzyme.

R Chakrabarti1, J B McCracken, D Chakrabarti, W W Souba.   

Abstract

A human genomic clone, psi GS, containing an intron-less glutamine synthetase (GS)-encoding pseudogene, was isolated by screening a human library. A sequence of 3004 bp, containing the GS coding region and both the 5' and 3' flanking sequences, was identified that exhibits all the characteristics of a processed pseudogene. The coding region shows 93% identity with the human GS cDNA (hGS) sequence and contains two frame-shifts and two termination codons. The coding sequence is flanked by a 9-bp AT repeat and a putative polyadenylation site, AATAAA, at the 3' end. Primer extension analysis and S1 nuclease mapping showed a transcription start point (tsp) 62 bp upstream from the start codon indicating a shorter untranslated region than hGS. Transfection of HeLa cells with cat constructs containing portions of the 5' flanking sequence showed the presence of a functional promoter/enhancer within 200 bp of the tsp, independent of its orientation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875583     DOI: 10.1016/0378-1119(94)00751-d

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  Reverse transcriptase: mediator of genomic plasticity.

Authors:  J Brosius; H Tiedge
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

2.  Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene.

Authors:  J Soret; R Gattoni; C Guyon; A Sureau; M Popielarz; E Le Rouzic; S Dumon; F Apiou; B Dutrillaux; H Voss; W Ansorge; J Stévenin; B Perbal
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

3.  Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.

Authors:  Amy E Steffek; Robert E McCullumsmith; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2008-06-17       Impact factor: 4.939

4.  Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors.

Authors:  Minjing Zou; Essa Y Baitei; Ali S Alzahrani; Futwan Al-Mohanna; Nadir R Farid; Brian Meyer; Yufei Shi
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

Review 5.  HMGA1-pseudogenes and cancer.

Authors:  Marco De Martino; Floriana Forzati; Claudio Arra; Alfredo Fusco; Francesco Esposito
Journal:  Oncotarget       Date:  2016-05-10

6.  Assessing the genomic evidence for conserved transcribed pseudogenes under selection.

Authors:  Amit N Khachane; Paul M Harrison
Journal:  BMC Genomics       Date:  2009-09-15       Impact factor: 3.969

7.  Nanog retrotransposed genes with functionally conserved open reading frames.

Authors:  Morag Robertson; Frances Stenhouse; Douglas Colby; Jamie R K Marland; Jennifer Nichols; Susan Tweedie; Ian Chambers
Journal:  Mamm Genome       Date:  2006-07-14       Impact factor: 2.957

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.